
In vitro activity of cefbuperazone and other antimicrobial agents against isolates from the female genital tract
Author(s) -
Marilyn OhmSmith,
Richard L. Sweet,
W K Hadley
Publication year - 1985
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.27.6.958
Subject(s) - moxalactam , antimicrobial , anaerobic bacteria , microbiology and biotechnology , metronidazole , clindamycin , cephalosporin , biology , bacteria , antibiotics , antibacterial agent , genetics
Cefbuperazone (BMY 25182), a new cephamycin, showed activity similar to those of moxalactam and other cephalosporin-cephamycins against aerobic and anaerobic bacteria from female genital tract infections. MICs of the antimicrobial agents were less than or equal to 16 micrograms/ml for greater than 97% of organisms tested. All of the anaerobic bacteria tested were susceptible to clindamycin, metronidazole, and chloramphenicol.